AU7285696A - Administration by inhalation of 2-amino-6n-propylamino-4,5,6,7-tetrahydrobenzothiazol, in particular of its (-)enantiomer and its pharmacologically tolerable acid addition salts - Google Patents

Administration by inhalation of 2-amino-6n-propylamino-4,5,6,7-tetrahydrobenzothiazol, in particular of its (-)enantiomer and its pharmacologically tolerable acid addition salts

Info

Publication number
AU7285696A
AU7285696A AU72856/96A AU7285696A AU7285696A AU 7285696 A AU7285696 A AU 7285696A AU 72856/96 A AU72856/96 A AU 72856/96A AU 7285696 A AU7285696 A AU 7285696A AU 7285696 A AU7285696 A AU 7285696A
Authority
AU
Australia
Prior art keywords
tetrahydrobenzothiazol
propylamino
enantiomer
inhalation
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72856/96A
Inventor
Volkmar Haselbarth
Michael Dr. Herschel
Richard Reichl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Publication of AU7285696A publication Critical patent/AU7285696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU72856/96A 1995-10-04 1996-10-04 Administration by inhalation of 2-amino-6n-propylamino-4,5,6,7-tetrahydrobenzothiazol, in particular of its (-)enantiomer and its pharmacologically tolerable acid addition salts Abandoned AU7285696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19536916 1995-10-04
DE19536916A DE19536916A1 (en) 1995-10-04 1995-10-04 Inhalative application of 2-amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole, in particular its (-) - enantiomer, and their pharmacologically acceptable acid addition salts
PCT/EP1996/004327 WO1997012614A1 (en) 1995-10-04 1996-10-04 Administration by inhalation of 2-amino-6n-propylamino-4,5,6,7-tetrahydrobenzothiazol, in particular of its (-)enantiomer and its pharmacologically tolerable acid addition salts

Publications (1)

Publication Number Publication Date
AU7285696A true AU7285696A (en) 1997-04-28

Family

ID=7773972

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72856/96A Abandoned AU7285696A (en) 1995-10-04 1996-10-04 Administration by inhalation of 2-amino-6n-propylamino-4,5,6,7-tetrahydrobenzothiazol, in particular of its (-)enantiomer and its pharmacologically tolerable acid addition salts

Country Status (4)

Country Link
AU (1) AU7285696A (en)
DE (1) DE19536916A1 (en)
WO (1) WO1997012614A1 (en)
ZA (1) ZA968315B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653969A1 (en) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg New aqueous pharmaceutical preparation for the production of propellant-free aerosols

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2839431A1 (en) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Tranquilliser and hypertonic for heart and vascular disease treatment - contg. 1-(2-nitro-5-methylphenoxy)-3-tert.butyl-aminopropan-2-ol
ATE45735T1 (en) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K TETRAHYDRO-BENZTHIAZOLE, THEIR PRODUCTION AND USE AS INTERMEDIATE OR MEDICINAL PRODUCTS.

Also Published As

Publication number Publication date
ZA968315B (en) 1997-04-04
WO1997012614A1 (en) 1997-04-10
DE19536916A1 (en) 1997-04-10

Similar Documents

Publication Publication Date Title
EP1574219A3 (en) Method of inhibiting fibrosis with a somatostatin agonist
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU5945296A (en) Medicament for nasal administration
AU1881795A (en) Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
AU3261193A (en) Amino acid derivatives as paf-receptor antagonists
AU7214796A (en) Novel amino acid derivatives, their preparation and use
WO1999033450A3 (en) Pharmaceutical composition containing sibutramine and orlistat
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
EP1440690A3 (en) Treatment of neurotic disorders
CA2113916A1 (en) 6-Chloro-5-Fluoro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide as an Analgesic and Anti-Inflammatory Agent
AU1614097A (en) Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-feranemethanamine, its enantiomers, and their pharmaceutically acceptable acid addition salts
AU6612596A (en) Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-,1-bisphosphonic acid and its salts
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
IL118727A (en) (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
CA2256007A1 (en) Substituted heterocyclic benzocycloalkenes and their use as analgesic
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
AU2620600A (en) Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
AU7285696A (en) Administration by inhalation of 2-amino-6n-propylamino-4,5,6,7-tetrahydrobenzothiazol, in particular of its (-)enantiomer and its pharmacologically tolerable acid addition salts
HUP0102447A3 (en) Novel octahydro-6,10-dioxo-6h-pyridazino/1,2a//1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds
AU6944696A (en) Novel phenylacetic acid derivatives and medicinal composition containing the same
ITTO950554A0 (en) ACID AROMATIC DIAMIDES WITH ANTIGASTRINIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL USE
AU6929596A (en) Novel carboxylic acid derivatives, their preparation and use
CA2208630A1 (en) 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use
AU8379091A (en) New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
AU5635496A (en) Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid